Skip to content
  • Intranet
  • Annuaire
  • Contact
Menu
  • Intranet
  • Annuaire
  • Contact
bluesky-icon
Search
  • Institut
    • Annuaire
    • Contact
  • Équipes
  • Publications
    • Publications (HAL)
    • Brevets
  • News
  • Événement
  • Plateforme
  • Recrutement
Menu
  • Institut
    • Annuaire
    • Contact
  • Équipes
  • Publications
    • Publications (HAL)
    • Brevets
  • News
  • Événement
  • Plateforme
  • Recrutement

Publication authors: Pascal Rathelot

Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial Pharmacophore

Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay

Tandem synthesis and in vitro antiplasmodial evaluation of new naphtho[2,1-d] thiazole derivatives

Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series

Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium

Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series

Using the Sonogashira Reaction for Preparing a New Fragment Library based on the 3-alkynylimidazo[1,2-alpha] pyridine Scaffold

Discovery of new hit-molecules targeting Plasmodium falciparum through a global SAR study of the 4-substituted-2-trichloromethylquinazoline antiplasmodial scaffold

Pertinence of Off-label Prescriptions of Innovating and Expensive Drugs in a University Hospital

Targeted Based Therapies in Metastatic Breast Cancer: Future Evolution

Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents

mediEVAL: a New Evaluating Tool for the Medication-use System

Targeting the human parasite Leishmania donovani: Discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series

Efficacy and Toxicity of Factor Xa Inhibitors

Efficacy and Future of the Aerosoltherapy in the Treatment of Cystic Fibrosis Patients Infected by Pseudomonas aeruginosa

Sonogashira cross-coupling reaction in 4-chloro-2-trichloromethylquinazoline series is possible despite a side dimerization reaction

Synthesis and Promising in Vitro Antiproliferative Activity of Sulfones of a 5-Nitrothiazole Series

Safety Review: Squalene and Thimerosal in Vaccines

Targeting the human malaria parasite Plasmodium falciparum: In vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline series

Discovery of a new antileishmanial hit in 8-nitroquinoline series

A New Synthetic Route to Original Sulfonamide Derivatives in 2-Trichloromethylquinazoline Series: A Structure-Activity Relationship Study of Antiplasmodial Activity

Organic Glues or Fibrin Glues from Pooled Plasma: Efficacy, Safety and Potential as Scaffold Delivery Systems

4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparum

Access to Original Vinylic Chlorides in the Quinazoline Series via a Monoelectronic Transfer Reaction Approach

Development and evaluation of an elective course on the pharmacist's role in disaster management in France

Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T.b. brucei hitcompound with improved pharmacokinetic properties

8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi

8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a] pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases

Body image and psychological distress in women with breast cancer: a French online survey on patients' perceptions and expectations

Factors limiting adherence to antiepileptic treatment: A French online patient survey

Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity

  • Intranet
  • Annuaire
  • Contact
  • Mentions Légales
Menu
  • Intranet
  • Annuaire
  • Contact
  • Mentions Légales

Welcome to

Institute of Radical Chemistry

Lost your password?